Down-regulation of CXCR2 on neutrophils in severe sepsis is mediated by inducible nitric oxide synthase-derived nitric oxide

American Journal of Respiratory and Critical Care Medicine

Volumn 175, Issue 5, 2007, Pages 490-497

  Rios Santos, Fabrício ^a,b   Alves Filho, José C ^a   Souto, Fabrício Oliveira ^b   Spiller, Fernando ^a   Freitas, Andressa ^a   Lotufo, Celina Monteiro C ^a   Soares, Milena Botelho Pereira ^c   Dos Santos, Ricardo Ribeiro ^c   Teixeira, Mauro M ^d   Cunha, Fernando De Queiroz ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

CXCR2; Neutrophil migration; Nitric oxide; Sepsis

Indexed keywords

AMINOGUANIDINE; CANAVANINE; CHEMOKINE RECEPTOR CXCR2; INDUCIBLE NITRIC OXIDE SYNTHASE; MACROPHAGE INFLAMMATORY PROTEIN 2; NITRIC OXIDE; PENICILLAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; GENE CONTROL; GENE DELETION; IMMUNOFLUORESCENCE; INFECTION; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS;

ANIMALS; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FLOW CYTOMETRY; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, INTERLEUKIN-8B; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 33847638979     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200601-103OC     Document Type: Article

References (51)

1. Wagner JG, Roth RA. Neutrophil migration during endotoxemia. J Leukoc Biol 1999;66:10-24.
2. Niggli V. Signaling to migration in neutrophils: importance of localized pathways. Int J Biochem Cell Biol 2003;35:1619-1638.
3. Simon SI, Green CE. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu Rev Biomed Eng 2005;7:151-185.
4. Alves-Filho JC, Tavares-Murta BM, Barja-Fidalgo C, Benjamim CF, Basile-Filho A, Arraes SM, Cunha FQ. Neutrophil function in severe sepsis. Endocr Metab Immune Disord Drug Targets 2006;6:151-158.
5. Alves-Filho JC, Benjamim C, Tavares-Murta BM, Cunha FQ. Failure of neutrophil migration toward infectious focus in severe sepsis: a critical event for the outcome of this syndrome. Mem Inst Oswaldo Cruz 2005;100:223-226.
6. Alves-Filho JC, de Freitas A, Russo M, Cunha FQ. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit Care Med 2006;34:461-470.
7. Benjamim CF, Silva JS, Fortes ZB, Oliveira MA, Ferreira SH, Cunha FQ. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect Immun 2002;70:3602-3610.
8. Benjamim CF, Ferreira SH, Cunha FQ. Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis 2000;182:214-223.
9. Crosara-Alberto DP, Darini AL, Inoue RY, Silva JS, Ferreira SH, Cunha FQ. Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus. Br J Pharmacol 2002;136:645-658.
10. Tavares-Murta BM, Machado JS, Ferreira SH, Cunha FQ. Nitric oxide mediates the inhibition of neutrophil migration induced by systemic administration of LPS. Inflammation 2001;25:247-253.
11. Rios-Santos F, Benjamim CF, Zavery D, Ferreira SH, Cunha FQ. A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligation and puncture sepsis. Shock 2003;19:61-65.
12. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-778.
13. Tavares-Murta BM, Zaparoli M, Ferreira RB, Silva-Vergara ML, Oliveira CH, Murta EF, Ferreira SH, Cunha FQ. Failure of neutrophil chemotactic function in septic patients. Crit Care Med 2002;30:1056-1061.
14. Cunha FQ, Moss DW, Leal LM, Moncada S, Liew FY. Induction of macrophage parasiticidal activity by Staphylococcus aureus and exotoxins through the nitric oxide synthesis pathway. Immunology 1993; 78:563-567.
15. Ghaffari A, Miller CC, McMullin B, Ghahary A. Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide 2005;14:21-29.
16. Broaddus VC, Boylan AM, Hoeffel JM, Kim KJ, Sadick M, Chuntharapai A, Hebert CA. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol 1994;152: 2960-2967.
17. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992;267:16283-16287.
18. Ahuja SK, Murphy PM. The CXC chemokines growth-regulated oncogene (GRO)α, GROβ, GROγ, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 1996;271:20545-20550.
19. Bozic CR, Gerard NP, von Uexkull-Guldenband C, Kolakowski LF Jr, Conklyn MJ, Breslow R, Showell HJ, Gerard C. The murine interleukin 8 type B receptor homologue and its ligands: expression and biological characterization. J Biol Chem 1994;269:29355-29358.
20. Jones SA, Moser B, Thelen M. A comparison of post-receptor signal transduction events in Jurkat cells transfected with either IL-8R1 or IL-8R2: chemokine mediated activation of p42/p44 MAP-kinase (ERK-2). FEBS Lett 1995;364:211-214.
21. Chuntharapai A, Kim KJ. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol 1995;155:2587-2594.
22. Tateda K, Moore TA, Newstead MW, Tsai WC, Zeng X, Deng JC, Chen G, Reddy R, Yamaguchi K, Standiford TJ. Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect Immun 2001;69:2017-2024.
23. Mehrad B, Strieter RM, Moore TA, Tsai WC, Lira SA, Standiford TJ. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J Immunol 1999;163:6086-6094.
24. Tsai WC, Strieter RM, Mehrad B, Newstead MW, Zeng X, Standiford TJ. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect Immun 2000;68:4289-4296.
25. Moore TA, Newstead MW, Strieter RM, Mehrad B, Beaman BL, Standiford TJ. Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in amurine model of pulmonary Nocardia asteroides infection. J Immunol 2000;164:908-915.
26. Prado GN, Suzuki H, Wilkinson N, Cousins B, Navarro J. Role of the C terminus of the interleukin 8 receptor in signal transduction and internalization. J Biol Chem 1996;271:19186-19190.
27. Sabroe I, Williams TJ, Hebert CA, Collins PD. Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J Immunol 1997;158:1361-1369.
28. Cummings CJ, Martin TR, Frevert CW, Quan JM, Wong VA, Mongovin SM, Hagen TR, Steinberg KP, Goodman RB. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol 1999;162:2341-2346.
29. Tarlowe MH, Duffy A, Kannan KB, Itagaki K, Lavery RF, Livingston DH, Bankey P, Hauser CJ. Prospective study of neutrophil chemokine responses in trauma patients at risk for pneumonia. Am J Respir Crit Care Med 2005;171:753-759.
30. Quaid GA, Cave C, Robinson C, Williams MA, Solomkin JS. Preferential loss of CXCR-2 receptor expression and function in patients who have undergone trauma. Arch Surg 1999;134:1367-1371 (discussion 1371-1372).
31. Chishti AD, Shenton BK, Kirby JA, Baudouin SV. Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med 2004;30:605-611.
32. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 1980;29:189-201.
33. Bertini R, Allegretti M, Bizzarri C, Moriconi A, Locati M, Zampella G, Cervellera MN, Di Cioccio V, Cesta MC, Galliera E, et al. Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proc Natl Acad Sci USA 2004;101:11791-11796.
34. Cotter MJ, Norman KE, Hellewell PG, Ridger VC. A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. Am J Pathol 2001;159:473-481.
35. Fraticelli A, Serrano CV Jr, Bochner BS, Capogrossi MC, Zweier JL. Hydrogen peroxide and superoxide modulate leukocyte adhesion-molecule expression and leukocyte endothelial adhesion. Biochim Biophys Acta 1996;1310:251-259.
36. Rose JJ, Foley JF, Murphy PM, Venkatesan S. On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2. J Biol Chem 2004;279:24372-24386.
37. Adams JM, Hauser CJ, Livingston DH, Lavery RF, Fekete Z, Deitch EA. Early trauma polymorphonuclear neutrophil responses to chemokines are associated with development of sepsis, pneumonia, and organ failure. J Trauma 2001;51:452-456. (Discussion 456-457.)
38. Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 1994;12:593-633.
39. Ben-Baruch A, Grimm M, Bengali K, Evans GA, Chertov O, Wang JM, Howard OM, Mukaida N, Matsushima K, Oppenheim JJ. The differential ability of IL-8 and neutrophil-activating peptide-2 to induce attenuation of chemotaxis is mediated by their divergent capabilities to phosphorylate CXCR2 (IL-8 receptor B). J Immunol 1997;158: 5927-5933.
40. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol 2001;78:57-110.
41. Arraes SM, Freitas MS, da Silva SV, de Paula Neto HA, Alves-Filho JC, Martins MA, Basile-Filho A, Tavares-Murta BM, Barja-Fidalgo C, Cunha FQ. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 2006;108:2906-2913.
42. Sato Y, Van Eeden SF, English D, Hogg JC. Pulmonary sequestration of polymorphonuclear leukocytes released from bone marrow in bacteremic infection. Am J Physiol 1998;275:L255-L261.
43. Tanji-Matsuba K, van Eeden SF, Saito Y, Okazawa M, Klut ME, Hayashi S, Hogg JC. Functional changes in aging polymorphonuclear leukocytes. Circulation 1998;97:91-98.
44. Khandaker MH, Mitchell G, Xu L, Andrews JD, Singh R, Leung H, Madrenas J, Ferguson SS, Feldman RD, Kelvin DJ. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-α-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 1999;93:2173-2185.
45. Ziolo MT, Katoh H, Bers DM. Expression of inducible nitric oxide synthase depresses β-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation 2001;104:2961-2966.
46. Stojanovic MO, Ziolo MT, Wahler GM, Wolska BM. Anti-adrenergic effects of nitric oxide donor SIN-1 in rat cardiac myocytes. Am J Physiol Cell Physiol 2001;281:C342-C349.
47. 2+ transients. Circulation 2004;109:1886-1891.
48. Cahill PA, Redmond EM, Foster C, Sitzmann JV. Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells. Eur J Pharmacol 1995;288:219-229.
49. Maggio R, Barbier P, Toso A, Barletta D, Corsini GU. Sodium nitroprusside induces internalization of muscarinic receptors stably expressed in Chinese hamster ovary cell lines. J Neurochem 1995;65:943-946.
50. Lewis SJ, Hoque A, Walton TM, Kooy NW. Potential role of nitration and oxidation reactions in the effects of peroxynitrite on the function of β-adrenoceptor sub-types in the rat. Eur J Pharmacol 2005;518:187-194.
51. Giuntini J, Giusti L, Lucacchini A, Mazzoni MR. Modulation of A1 adenosine receptor signaling by peroxynitrite. Biochem Pharmacol 2004;67:375-383.